Treatment of Central Obesity with Unani Medicine Jawarish-e-Bisbasa.
- Conditions
- Health Condition 1: E668- Other obesityHealth Condition 2: null- Saman e Mufrit (Central Obesity)
- Registration Number
- CTRI/2018/08/015404
- Lead Sponsor
- Central Council for Research in Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients of Saman Mufrit (Central Obesity) presenting with the following:
1 BMI Male equal to or less than 34.99 kg/m2 and Female equal to or less than 32.49 kg/m2)
2 Waist Circumference (more than 94cms in Males and more than 80 cms in Females)
3 Waist â?? to â?? hip ratio between (more than 80cm to less than 1m), (Female 80 to 85 and male more than 90cm to less than 1m)
4 Saggital Abdominal Diameter (SAD) more than 25 cms
5 Patients presenting with central obesity with or without following complaints:
I.Heart burn
II.Fullness of stomach
III.Breathing difficulties
IV.Sleep apnea
1.Medications causing secondary weight gain e.g.Phenothiazines, sodium valproate, carbamazepine, lithium, glucocorticoids, thiazolidinedioneâ??s, sulphonylureas, adrenergic antagonists, etc
2.Patient on Oral contraceptive pills or Hormone Replacement therapy
3.Patient having systemic illness requiring long term treatment
4.Patients unable to exercise
5.Pregnant and lactating females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in sign and symptoms of Saman e Mufrit (Central Obesity)Timepoint: 8 weeks
- Secondary Outcome Measures
Name Time Method Hematological and biochemical assessments for safetyTimepoint: 8 weeks